Khaitan, TT&A, Hogan Lovells Act On Symbiotec Pharmalab’s Proposed IPO Pharmaceuticals December 27, 2025 Capital Markets – Equity
CAM & Khaitan Advised On QIP By Navine Fluorine Worth ₹750 Cr Manufacturing July 28, 2025 Capital Markets
Khaitan & Co. Advised Ganesh Consumer Products On Filing DRHP For It’s Proposed IPO FMCG January 4, 2025 Capital Markets
